Published in Brain Topogr on August 14, 2012
Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement (2014) 1.85
Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. Mov Disord (2013) 1.45
Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance. Neuroimage (2014) 1.09
Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One (2012) 0.98
Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry. Neuroimage (2014) 0.97
The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer's disease. Front Aging Neurosci (2014) 0.92
Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack. Neuroimage Clin (2013) 0.91
A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative. Biol Psychiatry (2013) 0.86
Domain adaptation for Alzheimer's disease diagnostics. Neuroimage (2016) 0.84
Prediction of pediatric unipolar depression using multiple neuromorphometric measurements: a pattern classification approach. J Psychiatr Res (2015) 0.84
Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort. Front Aging Neurosci (2014) 0.84
Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness. Neuroimage Clin (2014) 0.84
Abnormal changes of multidimensional surface features using multivariate pattern classification in amnestic mild cognitive impairment patients. J Neurosci (2014) 0.84
TheHiveDB image data management and analysis framework. Front Neuroinform (2014) 0.83
APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease. Psychiatry Res (2013) 0.83
Modular reorganization of brain resting state networks and its independent validation in Alzheimer's disease patients. Front Hum Neurosci (2013) 0.81
Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease. Aging Cell (2014) 0.81
A practical guideline for intracranial volume estimation in patients with Alzheimer's disease. BMC Bioinformatics (2015) 0.81
Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer. Biomed Res Int (2015) 0.81
Predicting progression of Alzheimer's disease using ordinal regression. PLoS One (2014) 0.80
A comparison of machine learning methods for classification using simulation with multiple real data examples from mental health studies. Stat Methods Med Res (2013) 0.80
Significance of normalization on anatomical MRI measures in predicting Alzheimer's disease. ScientificWorldJournal (2014) 0.79
Sex differences in impulsivity and brain morphometry in methamphetamine users. Brain Struct Funct (2016) 0.79
A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease. PLoS One (2015) 0.79
A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity. Neuroimage Clin (2016) 0.78
An ensemble-of-classifiers based approach for early diagnosis of Alzheimer's disease: classification using structural features of brain images. Comput Math Methods Med (2014) 0.78
Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage Clin (2016) 0.77
The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects. Brain Topogr (2015) 0.77
Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes. Transl Psychiatry (2015) 0.77
An efficient approach for differentiating Alzheimer's disease from normal elderly based on multicenter MRI using gray-level invariant features. PLoS One (2014) 0.76
The cortical thickness phenotype of individuals with DISC1 translocation resembles schizophrenia. J Clin Invest (2015) 0.76
Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts. Brain Topogr (2014) 0.76
Education and Genetic Risk Modulate Hippocampal Structure in Alzheimer's Disease. Aging Dis (2016) 0.76
Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry. Neuroimage Clin (2016) 0.75
Simultaneous total intracranial volume and posterior fossa volume estimation using multi-atlas label fusion. Hum Brain Mapp (2016) 0.75
Cardiovascular risk and hippocampal thickness in Alzheimer's disease. Int J Alzheimers Dis (2013) 0.75
Subcortical Shape Changes, Hippocampal Atrophy and Cortical Thinning in Future Alzheimer's Disease Patients. Front Aging Neurosci (2017) 0.75
Neuroimaging chronic pain: what have we learned and where are we going? Future Neurol (2014) 0.75
A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers. J Alzheimers Dis (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology (1983) 30.77
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A (2000) 19.87
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp (1999) 16.32
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
Sequence-independent segmentation of magnetic resonance images. Neuroimage (2004) 11.36
Forecasting the global burden of Alzheimer's disease. Alzheimers Dement (2007) 10.01
A hybrid approach to the skull stripping problem in MRI. Neuroimage (2004) 9.59
Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach. J Cogn Neurosci (1993) 8.64
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging (2001) 8.14
Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage (2011) 5.24
MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology (1992) 4.87
Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain (1996) 4.61
Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage (2010) 4.28
Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans Med Imaging (2007) 4.18
Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem (2007) 4.04
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage (2004) 3.61
Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology (2009) 2.90
High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex (2009) 2.88
Consistent neuroanatomical age-related volume differences across multiple samples. Neurobiol Aging (2009) 2.08
Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage (2010) 1.99
Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage (2012) 1.87
Ensemble sparse classification of Alzheimer's disease. Neuroimage (2012) 1.84
An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement (2007) 1.83
Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One (2011) 1.66
Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage (2011) 1.64
The Toronto traumatic brain injury study: injury severity and quantified MRI. Neurology (2008) 1.61
Data integration in plant biology: the O2PLS method for combined modeling of transcript and metabolite data. Plant J (2007) 1.58
Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol (1999) 1.48
Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage (2010) 1.44
The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry (2011) 1.35
MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci (2009) 1.28
Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J Proteome Res (2006) 1.25
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage (2011) 1.24
Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc (2008) 1.20
Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology (2011) 1.13
Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis (2010) 1.12
Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One (2011) 1.10
Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study. Neurobiol Aging (2009) 1.09
Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging (2010) 1.08
Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology. Neurobiol Aging (2011) 1.06
Tau proteins and neurofibrillary degeneration. Brain Pathol (1991) 1.03
Role of imaging techniques in the diagnosis of dementia. Br J Radiol (2007) 1.00
APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord (2010) 1.00
Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice. Neurobiol Aging (2007) 0.98
Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease. J Alzheimers Dis (2011) 0.98
Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. J Alzheimers Dis (2010) 0.91
In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment. BMC Neurosci (2009) 0.87
Carbamazepine treatment recovered low N-acetylaspartate+N-acetylaspartylglutamate (tNAA) levels in the megencephaly mouse BALB/cByJ-Kv1.1(mceph/mceph). Neurobiol Dis (2006) 0.82
Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis (2011) 0.81
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry (2011) 2.47
A lateralized brain network for visuospatial attention. Nat Neurosci (2011) 2.26
Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain (2002) 2.26
Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp (2006) 2.00
Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. Neuron (2010) 1.96
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage (2012) 1.87
Isotropic resolution diffusion tensor imaging with whole brain acquisition in a clinically acceptable time. Hum Brain Mapp (2002) 1.60
A modified damped Richardson-Lucy algorithm to reduce isotropic background effects in spherical deconvolution. Neuroimage (2009) 1.59
Cognitive effects of nicotine in humans: an fMRI study. Neuroimage (2003) 1.59
Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination. Biol Psychiatry (2013) 1.49
The impact of rheologically controlled materials on the identification of airway compromise on the clinical and videofluoroscopic swallowing examinations. Dysphagia (2006) 1.47
Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage (2010) 1.44
Can spherical deconvolution provide more information than fiber orientations? Hindrance modulated orientational anisotropy, a true-tract specific index to characterize white matter diffusion. Hum Brain Mapp (2012) 1.37
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34
Neural response to pleasant stimuli in anhedonia: an fMRI study. Neuroreport (2003) 1.33
Early specialization for voice and emotion processing in the infant brain. Curr Biol (2011) 1.31
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci (2009) 1.30
Statistical parametric network analysis of functional connectivity dynamics during a working memory task. Neuroimage (2010) 1.29
In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry (2006) 1.29
Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. J Alzheimers Dis (2014) 1.29
Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation. Schizophr Res (2002) 1.27
An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo. Mol Ther (2007) 1.26
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage (2011) 1.24
Brain network analysis: separating cost from topology using cost-integration. PLoS One (2011) 1.23
Structural magnetic resonance imaging in eating disorders: a systematic review of voxel-based morphometry studies. Eur Eat Disord Rev (2011) 1.23
Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res (2003) 1.20
A computational morphometric MRI study of schizophrenia: effects of hallucinations. Cereb Cortex (2002) 1.18
Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res (2003) 1.17
White matter integrity as a predictor of response to treatment in first episode psychosis. Brain (2013) 1.16
Heterozygous PAX6 mutation, adult brain structure and fronto-striato-thalamic function in a human family. Eur J Neurosci (2004) 1.16
Beyond cortical localization in clinico-anatomical correlation. Cortex (2012) 1.15
Intracranial volume estimated with commonly used methods could introduce bias in studies including brain volume measurements. Neuroimage (2013) 1.14
Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis (2010) 1.12
A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disord (2004) 1.12
Human attachment security is mediated by the amygdala: evidence from combined fMRI and psychophysiological measures. Hum Brain Mapp (2006) 1.11
Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J Alzheimers Dis (2012) 1.11
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease. J Neurol (2008) 1.11
Neural abnormalities during cognitive generation of affect in treatment-resistant depression. Biol Psychiatry (2003) 1.10
Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One (2011) 1.10
Neural correlates of British sign language comprehension: spatial processing demands of topographic language. J Cogn Neurosci (2002) 1.09
Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry (2002) 1.09
Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study. Neurobiol Aging (2009) 1.09
Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry (2013) 1.08
Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease. Neurobiol Aging (2010) 1.08
Separable enhancer sequences regulate the expression of the neural bHLH transcription factor neurogenin 1. Dev Biol (2004) 1.08
Influence of X chromosome and hormones on human brain development: a magnetic resonance imaging and proton magnetic resonance spectroscopy study of Turner syndrome. Biol Psychiatry (2005) 1.07
A diffusion tensor magnetic resonance imaging study of frontal cortex connections in very-late-onset schizophrenia-like psychosis. Am J Geriatr Psychiatry (2005) 1.07
A comprehensive testing protocol for MRI neuroanatomical segmentation techniques: Evaluation of a novel lateral ventricle segmentation method. Neuroimage (2011) 1.06
Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One (2011) 1.06
A blood gene expression marker of early Alzheimer's disease. J Alzheimers Dis (2013) 1.05
Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment. Psychiatry Res (2013) 1.05
The cerebellum and decision making under uncertainty. Brain Res Cogn Brain Res (2004) 1.03
Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol Psychiatry (2003) 1.01
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease. J Alzheimers Dis (2013) 1.01
APOE ε2 allele is associated with larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord (2010) 1.00
The antisocial brain: psychopathy matters. Arch Gen Psychiatry (2012) 0.99
Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis. Neuroradiology (2012) 0.99
Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One (2012) 0.98
Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease. J Alzheimers Dis (2011) 0.98
Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys. Cereb Cortex (2012) 0.97
Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex (2008) 0.95
White matter abnormalities and illness severity in major depressive disorder. Br J Psychiatry (2012) 0.92
Decay of prism aftereffects under passive and active conditions. Brain Res Cogn Brain Res (2004) 0.92
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression. J Alzheimers Dis (2011) 0.91
Pattern classification of response inhibition in ADHD: toward the development of neurobiological markers for ADHD. Hum Brain Mapp (2013) 0.91
Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls. J Alzheimers Dis (2010) 0.91
Emotional decision-making and its dissociable components in schizophrenia and schizoaffective disorder: a behavioural and MRI investigation. Neuropsychologia (2008) 0.91
Effects of age and gender on neural networks of motor response inhibition: from adolescence to mid-adulthood. Neuroimage (2013) 0.90
Disorder-specific predictive classification of adolescents with attention deficit hyperactivity disorder (ADHD) relative to autism using structural magnetic resonance imaging. PLoS One (2013) 0.90
The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration. Cancer Immunol Immunother (2006) 0.89
Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol (2006) 0.89
Evaluation of enhanced attention to local detail in anorexia nervosa using the embedded figures test; an FMRI study. PLoS One (2013) 0.89
Diffusion tensor imaging in sporadic and familial (D90A SOD1) forms of amyotrophic lateral sclerosis. Arch Neurol (2009) 0.89
Functional development of fronto-striato-parietal networks associated with time perception. Front Hum Neurosci (2011) 0.88
Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging (2011) 0.87
Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia. Behav Brain Res (2008) 0.87
The crystal structure of Trypanosoma cruzi arginine kinase. Proteins (2007) 0.87
Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Clin Immunol (2009) 0.87
Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia. Eur J Haematol (2013) 0.87
Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways. J Neurol (2007) 0.87
Allocentric spatial memory activation of the hippocampal formation measured with fMRI. Neuropsychology (2004) 0.87
Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study. Eur J Haematol (2010) 0.86
Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. PLoS One (2013) 0.84
Is the subcallosal medial prefrontal cortex a common site of atrophy in Alzheimer's disease and frontotemporal lobar degeneration? Front Aging Neurosci (2012) 0.84
Neural and psychological maturation of decision-making in adolescence and young adulthood. J Cogn Neurosci (2013) 0.83
Quantitative and qualitative assessment of structural magnetic resonance imaging data in a two-center study. BMC Med Imaging (2012) 0.83
Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population. J Neurodev Disord (2013) 0.83
Structural magnetic resonance imaging predictors of responsiveness to cognitive behaviour therapy in psychosis. Schizophr Res (2009) 0.83
Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze. J Psychopharmacol (2010) 0.81
Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease. Aging Cell (2014) 0.81
Cortical activation during motor imagery is reduced in Amyotrophic Lateral Sclerosis. Brain Res (2007) 0.81